These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3726055)

  • 21. [Tacrine against Alzheimer disease? Still uncertain for which patients may the treatment be beneficial].
    Wallin A
    Lakartidningen; 1996 Jan; 93(1-2):22-4. PubMed ID: 8544526
    [No Abstract]   [Full Text] [Related]  

  • 22. Are drugs targeted at Alzheimer's disease useful? 2. Insufficient evidence of worthwhile benefit.
    Byrne EJ; Arie T
    BMJ; 1990 Apr; 300(6732):1132-3; discussion 1131. PubMed ID: 2160850
    [No Abstract]   [Full Text] [Related]  

  • 23. Geriatric neuropsychopharmacology.
    Psychopharmacol Bull; 1981 Jul; 17(3):141-2. PubMed ID: 7291460
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnosis and treatment of Alzheimer's disease.
    Grossberg GT
    J Clin Psychiatry; 2003; 64 Suppl 9():3-6. PubMed ID: 12934967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA approves groundbreaking Alzheimer's drug.
    Provider; 2004 Feb; 30(2):24, 27. PubMed ID: 14964917
    [No Abstract]   [Full Text] [Related]  

  • 27. Research design issues: antialuminum drug studies in Alzheimer's disease.
    Shore D; Wyatt RJ
    Clin Neuropharmacol; 1982 Dec; 5(4):337-43. PubMed ID: 7159877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral physostigmine in Alzheimer's disease.
    Davis KL; Mohs RC; Davis BM; Horvath TB; Greenwald BS; Rosen WG; Levy MI; Johns CA
    Psychopharmacol Bull; 1983; 19(3):451-3. PubMed ID: 6635123
    [No Abstract]   [Full Text] [Related]  

  • 29. Tacrine granted marketing approval for Alzheimer's disease.
    Clin Pharm; 1993 Dec; 12(12):873, 876. PubMed ID: 8137602
    [No Abstract]   [Full Text] [Related]  

  • 30. [Drug treatment of Alzheimer's disease].
    González González JA
    An R Acad Nac Med (Madr); 2001; 118(3):527-41; discussion 541-4. PubMed ID: 11783035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease: pathophysiology and the hope for therapy.
    Brumback RA; Leech RW
    J Okla State Med Assoc; 1994 Mar; 87(3):103-11. PubMed ID: 8195921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent advances in the management of Alzheimer's disease.
    Bhattacharya SK
    J Indian Med Assoc; 2000 Apr; 98(4):180-1, 183. PubMed ID: 11016182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study.
    Hampel H; Ewers M; Bürger K; Annas P; Mörtberg A; Bogstedt A; Frölich L; Schröder J; Schönknecht P; Riepe MW; Kraft I; Gasser T; Leyhe T; Möller HJ; Kurz A; Basun H
    J Clin Psychiatry; 2009 Jun; 70(6):922-31. PubMed ID: 19573486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease drug development and testing at the National Institute on Aging.
    Buckholtz NS
    Psychopharmacol Bull; 1994; 30(1):15-7. PubMed ID: 7972623
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurotransmitter replacement therapy in Alzheimer's disease.
    Mohr E; Mendis T; Rusk IN; Grimes JD
    J Psychiatry Neurosci; 1994 Jan; 19(1):17-23. PubMed ID: 7908537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic drug studies in dementia and depression.
    Newhouse PA
    Adv Exp Med Biol; 1990; 282():65-76. PubMed ID: 2088086
    [No Abstract]   [Full Text] [Related]  

  • 37. Medications for the treatment of Alzheimer's disease.
    Lampley-Dallas VT
    J Okla State Med Assoc; 2001 Aug; 94(8):347-9. PubMed ID: 11515383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
    Cummings JL; Mendez MF
    Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advancing Alzheimer's disease drug review as a national priority.
    Perry DP
    Alzheimers Dement; 2009 Mar; 5(2):180-1. PubMed ID: 19328455
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dementia and Alzheimer's disease. Indications, diagnosis, and treatment.
    Golden R
    Minn Med; 1995 Jan; 78(1):25-9. PubMed ID: 7877576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.